Digital Therapeutix

About Digital Therapeutix

At Digital Therapeutix, we are doing something different that is important to our customers. We are pioneering the future of infectious disease treatment through precision phage therapy as an advanced alternative to antibiotics. We’ve developed QUINT, our bacteriophage matching prototype, and are actively building QUINTx, our AI-powered extension designed to transform infectious disease care across clinical, veterinary, and agricultural settings. Together, QUINT and QUINTx: • Reduce hospital stays and healthcare costs • Accelerate phage matching for physicians and veterinarians • Improve outcomes for patients with resistant infections • Support pet owners, livestock producers, and farmers in protecting animal and crop health We deliver transformative digital health solutions that empower laboratory services and their partners to respond to antibiotic resistance with precision, speed, and scalability. Our mission is to ensure equitable access to phage-based treatments so that innovation reaches those who need it most. By integrating advanced bioinformatics, genomic analysis, and AI, we’re building a more innovative, more connected health ecosystem. Together, we are redefining the fight against antibiotic resistance. Let’s build a healthier future, one solution at a time.

View contact profiles from Digital Therapeutix